Cargando…
Inter‐lab concordance of variant classifications establishes clinical validity of expanded carrier screening
Expanded carrier screening (ECS) panels that use next‐generation sequencing aim to identify pathogenic variants in coding and clinically relevant non‐coding regions of hundreds of genes, each associated with a serious recessive condition. ECS has established analytical validity and clinical utility,...
Autores principales: | Kaseniit, Kristjan E., Collins, Elizabeth, Lo, Christine, Moyer, Krista, Mar‐Heyming, Rebecca, Kang, Hyunseok P., Muzzey, Dale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852020/ https://www.ncbi.nlm.nih.gov/pubmed/31170325 http://dx.doi.org/10.1111/cge.13582 |
Ejemplares similares
-
Genetic ancestry analysis on >93,000 individuals undergoing expanded carrier screening reveals limitations of ethnicity-based medical guidelines
por: Kaseniit, Kristjan E., et al.
Publicado: (2020) -
Clinical validity of expanded carrier screening: Evaluating the gene‐disease relationship in more than 200 conditions
por: Balzotti, Marie, et al.
Publicado: (2020) -
Systematic design and comparison of expanded carrier screening panels
por: Beauchamp, Kyle A, et al.
Publicado: (2018) -
The impact of HBB‐related hemoglobinopathies carrier status on fetal fraction in noninvasive prenatal screening
por: Putra, Manesha, et al.
Publicado: (2022) -
Screening for Tay‐Sachs disease carriers by full‐exon sequencing with novel variant interpretation outperforms enzyme testing in a pan‐ethnic cohort
por: Cecchi, Alana C., et al.
Publicado: (2019)